Asahi Kasei Pharma has announced the new application period for their annual “Open Innovation” solicitation of proposals for drug discovery research. Through collaboration with universities, research institutes, and companies around the world, Asahi Kasei Pharma has been supporting innovation in drug discovery since 2018 and will fund up to $200,000 US per year for each selected proposal of the upcoming round in 2023.
With “Global Specialty Pharma” highlighted as one of the 10 Growth Gears in their 2024 Medium-term Management Plan, endeavours like this for discovering new drugs for conditions with unmet needs will play a key role for growth in its Health Care Sector in the long term. Asahi Kasei Pharma look forward to supporting drug discovery research as trailblazers in the pharmaceuticals industry.
Application period: 5 Jan – 28 Feb 2023
Apply here.
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026
